norfloxacin has been researched along with Cardiovascular Diseases in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maged, A | 1 |
| Elgarahy, AM | 1 |
| Hlawitschka, MW | 1 |
| Haneklaus, NH | 1 |
| Gupta, AK | 1 |
| Bhatnagar, A | 1 |
| Stahlmann, R | 1 |
2 other studies available for norfloxacin and Cardiovascular Diseases
| Article | Year |
|---|---|
Synergistic mechanisms for the superior sorptive removal of aquatic pollutants via functionalized biochar-clay composite.
Topics: Adsorption; Cardiovascular Diseases; Charcoal; Clay; Environmental Pollutants; Gentian Violet; Human | 2023 |
Clinical toxicological aspects of fluoroquinolones.
Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease | 2002 |